Cargando…
The Development of Gonadotropins for Clinical Use in the Treatment of Infertility
The first commercially available gonadotropin product was a human chorionic gonadotropin (hCG) extract, followed by animal pituitary gonadotropin extracts. These extracts were effective, leading to the introduction of the two-step protocol, which involved ovarian stimulation using animal gonadotropi...
Autores principales: | Lunenfeld, Bruno, Bilger, Wilma, Longobardi, Salvatore, Alam, Veronica, D'Hooghe, Thomas, Sunkara, Sesh K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6616070/ https://www.ncbi.nlm.nih.gov/pubmed/31333582 http://dx.doi.org/10.3389/fendo.2019.00429 |
Ejemplares similares
-
Effect of Genetic Variants of Gonadotropins and Their Receptors on Ovarian Stimulation Outcomes: A Delphi Consensus
por: Conforti, Alessandro, et al.
Publicado: (2022) -
Time as an outcome measure in fertility-related clinical studies: long-awaited
por: Sunkara, Sesh K, et al.
Publicado: (2020) -
Optimising Follicular Development, Pituitary Suppression, Triggering and Luteal Phase Support During Assisted Reproductive Technology: A Delphi Consensus
por: Orvieto, Raoul, et al.
Publicado: (2021) -
Commentary: The Development of Gonadotropins for Clinical Use in the Treatment of Infertility
por: Beligotti, Fabiola
Publicado: (2020) -
Dose adjustment of follicle-stimulating hormone (FSH) during ovarian stimulation as part of medically-assisted reproduction in clinical studies: a systematic review covering 10 years (2007–2017)
por: Fatemi, Human, et al.
Publicado: (2021)